基因检测服务市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPHE100001383
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 193
Buy Now

【研究报告】基因检测服务市场规模预计将从2022年的34.2523亿美元增长到2030年的105.5629亿美元;预计 2022 年至 2030 年复合年增长率为 15.1%。
市场洞察和分析师观点:
基因检测,也称为 DNA 检测或基因分析,是一种医学和科学程序,涉及检查和分析个体的 DNA,以深入了解个体的基因组成和遗传信息。基因检测可以揭示个体基因组内的特定遗传变异、突变或改变,提供有关其遗传倾向、遗传特征、某些疾病风险等的信息。进行基因检测的目的有多种,包括诊断遗传性疾病、评估疾病风险、识别遗传性疾病的携带者状态、了解祖先和家谱以及指导个性化医疗。基因检测通常涉及对遗传物质样本(例如血液、唾液、口腔拭子或组织样本)进行分析,以检查个体的 DNA。
增长动力:
个性化医疗是利用患者个人信息的领域。遗传和环境数据提供最佳的医疗保健。它基于每个患者都是独特的并且需要个体化药物治疗的原则。由于它是一个快速发展的领域,目前已纳入多个医疗保健系统。 2003年人类基因组计划(HGP)的成功完成以及人类基因组测序成本的快速下降鼓励了一种新的医疗方法的发展,即个性化医疗。随着分子水平个性化数据存储库的不断扩大,分子诊断公司在释放价值方面处于得天独厚的优势。自巴拉克·奥巴马 (Barack Obama) 2015 年宣布启动精准医疗计划以来,人们对个性化医疗的认识有所提高。不仅在美国,而且在德国,个性化医疗(更广为人知的名称是个体化医疗 (IM))已获得关注。 2010年底,德国联邦教育和研究部(BMBF)将个性化医疗列为六大优先事项之一。它推出了名为“个体化医疗”的行动计划。此外,十万基因组计划还巩固了国家医疗服务体系作为世界上最先进医疗保健系统之一的地位。此外,该项目正在巩固个性化医疗的基础,这反过来又有助于基因检测服务市场的增长。
大规模药物发现是提高个性化医疗诊断的可行性和有用性的关键疾病和失调。基因组学是医学科学中发展最快的部门之一。它正在推动疾病研究方法以及疾病诊断和治疗的范式转变。基因检测已广泛应用于药物基因组学,也称为药物基因检测。它有助于加速药物发现及其开发。
法国还制定了一项名为“法国基因组医学 2025”的国家个性化医疗计划。 2016 年 6 月,国家生命与健康科学联盟主席兼 Inserm 首席执行官伊夫·利维 (Yves Lévy) 向总理曼努埃尔·瓦尔斯 (Manuel Valls) 提交了该计划。它呼吁医疗保健和制造公司试点基因组测序平台。该计划得到了政府的支持,并于 2020 年启动了 7.608 亿美元(6.7 亿欧元)的公共融资,用于基因组学和个性化医疗项目。预计未来十年内法国将成为基因组医学领域的领先国家。
2023 年 4 月是人类基因组计划完成 20 周年,这是法国国家科学史上的一个重要里程碑人类基因组研究所。现在,新的研究表明,使用基因检测进行精确处方最终已达到全球采用的临界点。这项经过同行评审的研究由剑桥大学出版社出版,研究了大规模使用临床遗传学所需的关键因素的成熟度。这些进步为支持基因组知情的临床决策被公认为新的护理标准铺平了道路。基因知情处方提供了成功降低医疗保健系统总体成本和改善个体患者护理的现实机制之一。基因检测通过了解疾病背后的科学、治疗的影响以及针对特定个体特征的疗法的开发,鼓励采用个性化医疗方法。它还可以利用基因检测结果帮助医护人员就疾病诊断、治疗和预防做出明智的决定,从而改善患者的治疗效果。
战略见解
报告细分和范围:
基因检测服务市场根据服务类型、疾病、服务提供商和地理位置进行细分。根据服务类型,基因检测服务市场分为预测性检测、携带者检测、产前检测、新生儿筛查、诊断性基因检测等。基因检测服务市场以疾病为基础,分为癌症、心血管疾病、代谢疾病和其他疾病。基因检测服务市场根据服务提供商分为一般检测服务和基于液体活检的CGP、MRD和MCED服务。基因检测服务市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。
细分分析:
基因检测服务市场根据服务类型分为产前检测、预测性检测、携带者检测、新生儿筛查、诊断性基因检测, 和别的。 2022年,诊断基因检测领域占据最大的市场份额,预计2022年至2030年市场复合年增长率最高。诊断检测的目的是识别特定的遗传或染色体疾病。该测试可检测特定的基因改变,但通常无法确定疾病的严重程度或发病年龄。单个基因的突变可能导致多种疾病,例如唐氏综合症、囊性纤维化和亨廷顿舞蹈症。当根据身体体征和症状怀疑特定病症时,基因检测通常可以确认诊断。诊断测试可以在出生前或人一生中的任何时间进行。诊断测试的结果可以影响一个人对医疗保健和疾病或紊乱管理的选择。基因检测的进步改变了许多遗传性疾病的风险评估和诊断格局。用于测试遗传疾病的先进工具使诊断服务提供商能够更好地了解和检测多种疾病,包括罕见疾病。在肿瘤学中,遗传变异可以确定患者患某种特定类型癌症的风险是否增加。例如,有乳腺癌家族史的患者可能会接受与乳腺癌高风险相关的遗传风险因素测试。
基因检测服务市场,按服务类型 – 2022 年和 2030 年
基于疾病基因检测服务市场分为癌症、心血管疾病、代谢疾病和其他疾病。癌症细分市场在 2022 年占据最大市场份额,预计 2022 年至 2030 年复合年增长率最高。
根据服务提供商,基因检测服务市场分为一般检测服务和基于液体活检的 CGP 、MRD 和 MCED 服务。 2022年,一般检测服务领域占据最大市场份额,预计2022-2030年复合年增长率最高。
区域分析:
基因检测服务市场主要分为北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。 2022 年,北美占据了主要市场份额,其次是欧洲。欧洲国家已采取多项举措来提高人们对基因检测优势的认识。最终目标是确保基因检测的各个方面都是高质量的,从而为患者提供精确可靠的结果。在欧洲,德国在基因检测服务市场中占有重要份额。医学遗传学已成为临床实践的重要组成部分。它为医生提供了有价值的诊断和分析症状前工具,他们可以更有效地利用这些工具来管理患者的疾病,甚至采取预防措施。根据 2022 年发表的一项题为“德国牙医、牙科专家和口腔颌面外科医生对罕见疾病的认识和知识”的研究,罕见疾病影响着该国约 400 万患者。此外,罕见疾病患病率的上升、针对利基治疗领域的定制检测试剂盒的开发以及基因检测试剂盒的采用,都有助于市场的快速增长。
根据 Globocan 2020,约 69,697 2020 年,德国报告了新的乳腺癌病例,占所有登记癌症病例的 11.1%。它造成20,579人死亡,各年龄段乳腺癌五年患病率为每10万人707.38人。在德国,近 16% 的三阴性乳腺癌女性携带 BRCA 突变。 2018年,德国政府宣布了一项战略,将BRCA基因检测纳入德国国家癌症计划,该计划于2008年启动,旨在确保具有乳腺癌高遗传风险的女性依法享有强化筛查和降低风险的权利选项。政府越来越注重监管和提高人们对基因检测的认识,这实际上导致了检测在全国范围内的更快采用。
在德国,无创产前检测于 2022 年成为公共报销检测。此外,报销计划的推出、对有效治疗方案的需求不断增加以及研究中心创新技术的实施预计将推动该国的市场扩张。人们对基因检测优势的认识不断增强、医疗保健专业人员的知识以及消费者在医疗保健方面支出的增加推动了基因检测服务市场的发展。
行业发展和未来机遇:
主要市场参与者采取的几项举措全球基因检测服务市场如下:
2023年10月,23andMe Holding Co宣布与GSK plc达成非排他性数据许可合作,使GSK能够利用23andMe数据库进行药物靶点发现和其他研究。2023年4月, Ambry Genetics Corp 与 LifeStrands Genomics 合作,在新加坡提供临床基因检测服务。两家公司将支持新加坡国家精准医学 (NPM) 计划第二阶段的临床实施试点 (CIP)。 2022 年 4 月,CENTOGENE 发布了 FilterTool,这是一款用于解释遗传数据的基于网络的应用程序。 FilterTool 与 CentoCloud 连接,可有效显示、过滤、选择和分类通过下一代测序 (NGS) 数据处理发现的相关遗传变异。竞争格局和主要公司:
Laboratory Corporation of America Holdings;照明公司; F.霍夫曼-拉罗氏有限公司; Exact Sciences Corp(基因组健康);奎斯特诊断公司;新基因组学实验室公司;欧洲金融科学公司; Centogene 股份公司;安布里遗传学; 23、和我;和 Bio-Rad Laboratories 是基因检测服务市场上排名前 10 位的基因检测公司。这些公司专注于展示新的高科技产品、技术进步和地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the global genetic testing services market?

The global genetic testing services market, by services type, is segmented into predictive testing, carrier testing, prenatal testing, diagnostic genetic testing, new-born screening, and others. The diagnostic genetic testing is expected to dominate the market owing to it is helpful to people who have a family history of a treatable genetic disorder and display no signs of illness.

What are genetic testing services?

Genetic testing services are medical tests that analyze an individual's DNA to identify potential genetic variations or mutations that may be associated with certain health conditions or diseases. These tests can provide valuable information about an individual's risk for developing certain diseases, as well as help guide personalized medical treatment and management plans.

Who are the major players in the global genetic testing services market worldwide?

The global genetic testing services market majorly consists of the players such as Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Illumina, Inc., Quest Diagnostics Incorporated, Exact Sciences Corp (Genomic Health), NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Centogene AG, and 23andMe, Inc., Bio-Rad Laboratories

What are the driving factors for the global genetic testing services market worldwide?

The factors driving the market include rising prevalence of genetic diseases and increasing awareness and acceptance of personalized medicines. However, social and ethical implications of genetic testing hinder the market growth.

The List of Companies - Genetic Testing Services Market 

  1. Laboratory Corporation of America Holdings
  2. F. Hoffmann-La Roche Ltd
  3. Illumina, Inc.
  4. Quest Diagnostics Incorporated
  5. Exact Sciences Corp (Genomic Health)
  6. NeoGenomics Laboratories, Inc.
  7. Eurofins Scientific
  8. Ambry Genetics
  9. Centogene AG
  10. 23andMe, Inc.
  11. Bio-Rad Laboratories

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports